newspaper
3:26-cv-05142 SALIX PHARMACEUTICALS, LTD. et al v. HETERO LABS LTD. et al
Corporate Disclosure Statement (aty) ( 2
May 7, 2026
1 min read
legal-news
SALIX PHARMACEUTICALS, LTD. et al v. HETERO LABS LTD. et al
26-cv-05142
D.N.J.
Advertisement
description
Case Summary
The plaintiffs, Salix Pharmaceuticals, Ltd. and others, filed a Corporate Disclosure Statement in the case 1:26-cv-05142. This statement is a required filing that discloses the corporate structure and ownership of the parties involved in the lawsuit. The statement provides transparency into the financial relationships between the parties.
No timeline activity recorded yet. This page will grow as rulings and filings land.
smart_toy
Juryvine case summary generated from primary court records.
How we verify our work.
fact_check
Docket Snapshot
account_balance
Court
D.N.J.
District of New Jersey · 3rd Circuit · NJ
tag
Docket
Not captured
Civil
timeline
Stage
Active litigation
Active
event
Filed
Date unavailable
Not in the available feed
new_releases
Latest Filing
1:26-cv-05142 SALIX PHARMACEUTICALS, LTD. et al v. HETERO LABS LTD. et al
Other · May 07, 2026
newspaper
Coverage
2 articles
1 source tracked
groups
Participants
1 Defendant, 2 Plaintiffs
3 linked entities
gavel
Judge
Not assigned in feed
What the record shows
This case is tied to District of New Jersey, a federal district court in NJ.
The newest docket activity we have is a other dated May 07, 2026.
The visible party/entity graph currently includes HETERO LABS LTD, 3:26-cv-05142 SALIX PHARMACEUTICALS, LTD, 1:26-cv-05142 SALIX PHARMACEUTICALS, LTD.
Press monitoring has found 2 related articles from 1 distinct source.
About This Court
District of New Jersey (D.N.J.) is a federal district court in the 3rd Circuit, NJ.
Advertisement
Case Timeline
2 events
info
Other
May 7, 2026
1:26-cv-05142 SALIX PHARMACEUTICALS, LTD. et al v. HETERO LABS LTD. et al
The plaintiffs, Salix Pharmaceuticals, Ltd. and others, filed a Corporate Disclosure Statement in the case 1:26-cv-05142. This statement is a required filing that discloses the corporate structure and ownership of the parties involved in the lawsuit. The statement provides transparency into the financial relationships between the parties.
info
Other
May 7, 2026
3:26-cv-05142 SALIX PHARMACEUTICALS, LTD. et al v. HETERO LABS LTD. et al
Salix Pharmaceuticals, Ltd. and other plaintiffs filed a Corporate Disclosure Statement in the case against Hetero Labs Ltd. and other defendants. This statement is a required filing that discloses the corporate structure and ownership of the plaintiffs. The filing is a procedural step in the ongoing litigation.
Advertisement
newspaper
2 articles
Press Coverage
newspaper
1:26-cv-05142 SALIX PHARMACEUTICALS, LTD. et al v. HETERO LABS LTD. et al
Corporate Disclosure Statement (aty) ( 2
May 7, 2026
1 min read
settings_backup_restore Data provenance expand_more
Sources tracked
1 outlet · 2 articles
Timeline events
2 records on file
Last updated
51 minutes ago
Juryvine aggregates docket entries from PACER/CourtListener, press coverage, and GDELT signals. Ingestion timestamps do not appear in the What Changed feed — that reflects real court activity only.